Go Pro

Drugs Made In America Acquisition II (DMII) Competitors

Drugs Made In America Acquisition II logo
$10.12 -0.01 (-0.05%)
As of 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

DMII vs. AGD, AWP, THQ, ACP, and THW

Should you buy Drugs Made In America Acquisition II stock or one of its competitors? Drugs Made In America Acquisition II's main competitors and comparable companies include Abrdn Global Dynamic Dividend Fund (AGD), abrdn Global Premier Properties Fund (AWP), Abrdn Healthcare Opportunities Fund (THQ), Abrdn Income Credit Strategies Fund (ACP), and Abrdn World Healthcare Fund (THW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does Drugs Made In America Acquisition II compare to Abrdn Global Dynamic Dividend Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and Abrdn Global Dynamic Dividend Fund (NYSE:AGD) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A
Abrdn Global Dynamic Dividend Fund$75.72MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Drugs Made In America Acquisition IIN/A N/A N/A
Abrdn Global Dynamic Dividend Fund N/A N/A N/A

In the previous week, Drugs Made In America Acquisition II and Drugs Made In America Acquisition II both had 2 articles in the media. Abrdn Global Dynamic Dividend Fund's average media sentiment score of 1.00 beat Drugs Made In America Acquisition II's score of 0.44 indicating that Abrdn Global Dynamic Dividend Fund is being referred to more favorably in the news media.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Abrdn Global Dynamic Dividend Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Abrdn Global Dynamic Dividend Fund beats Drugs Made In America Acquisition II on 2 of the 3 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to abrdn Global Premier Properties Fund?

abrdn Global Premier Properties Fund (NYSE:AWP) and Drugs Made In America Acquisition II (NASDAQ:DMII) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Global Premier Properties Fund$60.73MN/AN/AN/AN/A
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
abrdn Global Premier Properties FundN/A N/A N/A
Drugs Made In America Acquisition II N/A N/A N/A

In the previous week, Drugs Made In America Acquisition II had 1 more articles in the media than abrdn Global Premier Properties Fund. MarketBeat recorded 2 mentions for Drugs Made In America Acquisition II and 1 mentions for abrdn Global Premier Properties Fund. abrdn Global Premier Properties Fund's average media sentiment score of 1.00 beat Drugs Made In America Acquisition II's score of 0.44 indicating that abrdn Global Premier Properties Fund is being referred to more favorably in the media.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
abrdn Global Premier Properties Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

abrdn Global Premier Properties Fund and Drugs Made In America Acquisition II tied by winning 2 of the 4 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abrdn Healthcare Opportunities Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and Abrdn Healthcare Opportunities Fund (NYSE:THQ) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, profitability, valuation, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Drugs Made In America Acquisition IIN/A N/A N/A
Abrdn Healthcare Opportunities Fund N/A N/A N/A

In the previous week, Drugs Made In America Acquisition II and Drugs Made In America Acquisition II both had 2 articles in the media. Abrdn Healthcare Opportunities Fund's average media sentiment score of 1.00 beat Drugs Made In America Acquisition II's score of 0.44 indicating that Abrdn Healthcare Opportunities Fund is being referred to more favorably in the news media.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A
Abrdn Healthcare Opportunities Fund-$28.02MN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Abrdn Healthcare Opportunities Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Drugs Made In America Acquisition II beats Abrdn Healthcare Opportunities Fund on 2 of the 3 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abrdn Income Credit Strategies Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and Abrdn Income Credit Strategies Fund (NYSE:ACP) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A
Abrdn Income Credit Strategies Fund$85.32MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Drugs Made In America Acquisition IIN/A N/A N/A
Abrdn Income Credit Strategies Fund N/A N/A N/A

In the previous week, Drugs Made In America Acquisition II and Drugs Made In America Acquisition II both had 2 articles in the media. Abrdn Income Credit Strategies Fund's average media sentiment score of 1.00 beat Drugs Made In America Acquisition II's score of 0.44 indicating that Abrdn Income Credit Strategies Fund is being referred to more favorably in the news media.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Abrdn Income Credit Strategies Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Abrdn Income Credit Strategies Fund beats Drugs Made In America Acquisition II on 2 of the 3 factors compared between the two stocks.

How does Drugs Made In America Acquisition II compare to Abrdn World Healthcare Fund?

Drugs Made In America Acquisition II (NASDAQ:DMII) and Abrdn World Healthcare Fund (NYSE:THW) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Drugs Made In America Acquisition II
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Abrdn World Healthcare Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Company Net Margins Return on Equity Return on Assets
Drugs Made In America Acquisition IIN/A N/A N/A
Abrdn World Healthcare Fund N/A N/A N/A

In the previous week, Drugs Made In America Acquisition II and Drugs Made In America Acquisition II both had 2 articles in the media. Abrdn World Healthcare Fund's average media sentiment score of 1.25 beat Drugs Made In America Acquisition II's score of 0.44 indicating that Abrdn World Healthcare Fund is being referred to more favorably in the news media.

Company Overall Sentiment
Drugs Made In America Acquisition II Neutral
Abrdn World Healthcare Fund Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Drugs Made In America Acquisition IIN/AN/AN/AN/AN/A
Abrdn World Healthcare Fund$86.53MN/AN/AN/AN/A

Summary

Abrdn World Healthcare Fund beats Drugs Made In America Acquisition II on 2 of the 3 factors compared between the two stocks.

Get Drugs Made In America Acquisition II News Delivered to You Automatically

Sign up to receive the latest news and ratings for DMII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DMII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DMII vs. The Competition

MetricDrugs Made In America Acquisition IICapital Markets IndustryFinance SectorNASDAQ Exchange
Market CapN/A$5.71B$14.07B$13.08B
Dividend YieldN/A7.39%5.89%10.74%
P/E RatioN/A38.6729.5725.26
Price / SalesN/A1,204.72502.74104.62
Price / CashN/A48.3239.3750.58
Price / BookN/A3.733.706.24
Net IncomeN/A$417.15M$1.31B$347.70M
7 Day Performance0.05%1.02%0.89%1.92%
1 Month Performance0.25%1.39%1.93%1.05%
1 Year PerformanceN/A7.84%12.07%19.53%

Drugs Made In America Acquisition II Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMII
Drugs Made In America Acquisition II
N/A$10.13
0.0%
N/AN/A$0.00N/AN/A2
AGD
Abrdn Global Dynamic Dividend Fund
N/A$12.14
+0.0%
N/A+8.4%$0.00$75.72MN/AN/A
AWP
abrdn Global Premier Properties Fund
N/A$11.88
-1.0%
N/A+0.0%$0.00$60.73MN/AN/A
THQ
Abrdn Healthcare Opportunities Fund
N/A$19.00
+0.6%
N/A+24.4%$0.00-$28.02MN/A1,088
ACP
Abrdn Income Credit Strategies Fund
N/A$5.08
+1.1%
N/A-13.8%$0.00$85.32MN/AN/A

Related Companies and Tools


This page (NASDAQ:DMII) was last updated on 8/13/2026 by MarketBeat.com Staff.
From Our Partners